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Abstract
Backgroud: Foot-and-mouth disease (FMD) is one of the most contagious of all artiodactyl animal diseases, and its
infection has an obvious ability to spread over long distances and to contribute to epidemics in FMD-free areas.
A highly sensitive and specific method is required to detect FMDV. In this study, we evaluated the usefulness of a
bio-barcode assay (BCA) technique for detecting clinical samples of FMDV.
Methods: Highly sensitive gold nanopariticle (GNP) improved immuno-PCR (GNP-IPCR) which derived from the
bio-barcode assay (BCA) was designed for the detection of FMDV. The target viral particles were captured by a
polyclonal antibody coated on ELISA microplate, followed by adding GNP which was dually modified with
oligonucleotides and a FMDV specific monoclonal antibody (MAb) 1D11 to form a sandwiched immune complex.
After the formation of immuno-complex, the signal DNA was released by heating, and consequently characterized
by PCR and real time PCR.
Results: The detection limit of GNP-PCR could reach to 10 fg/ml purified FMDV particles, and the assay can detect
clinical samples of FMDV with highly sensitivity, while detect limit of conventional ELISA is 100 ng/ml in this study.
Conclusion: GNP-IPCR may provide a highly sensitive method for the detection of FMDV.
Backgroud
Foot-and-mouth disease virus (FMDV), which belongs
to the Aphthovirus genus of the family Picornaviridae, is
a single-stranded positive sense RNA virus of 8,500 bp
and is enclosed by an icosahedral capsid [1]. The virus
exists as seven serologically distinct types (O, A, C, Asia
1, SATs 1, 2, 3) [2]. The virus affects artiodactyl, espe-
cially cattle and swine, and FMD is one of the most
contagious of all animal diseases. In 2001, outbreaks of
FMD in Taiwan, South Korea and the United Kingdom
resulted in the slaughter of millions of animals and huge
economic losses [3]. This virus can survive in meat and
other animal products for a long periods [4], and FMD
is endemic in large area of South America, Asia, Africa,
and its infection has an obvious ability to spread over
long distances and to cause epidemics in FMD-free
areas.
Many methods have been developed to detect the
FMDV, such as ELISA [5], hybridization assays [6], con-
ventional RT-PCR [7] and real-time RT -PCR [8-14].
Generally, the sensitivity of ELISA is lower, but which
can detect antigens or antibodies. The sensitivity of PCR
is higher, but it can only detect DNA/RNA of the virus,
and can also lead to false-positive results. 朗读.
Recently, a new highly sensitive assay, namely bio-bar-
code amplification (BCA) assay, was developed for ultra-
sensitive detection of target proteins and nucleic acids,
the detection limit could reach the level of 30 attomolar
(aM) [15-17]. BCA combines the advantages of both
ELISA and PCR, it has not only the sensitivity of PCR,
but also can detect the antigens or antibodies. In the
BCA, gold nanoparticles (GNPs) could conjugate with
DNA and specific monoclonal antibody (Mab). Many
DNA immobilized on the surface of GNP would further
improve the sensitivity of conventional immuno-PCR
[18,19]. In this study, the application of BCA was evalu-
ated for detecting clinical FMD samples.* Correspondence: scarlettezhang@yahoo.com.cn
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Materials and methods
Cells and virus
BHK-21 cells were grown in MEM medium (Qingdatia-
nyi Co., China) containing 4% newborn calf serum
(PPA, Australia), and used to replicate FMDV. FMDV
strain China/99 specific MAb 1D11 and the polyclonal
antibody rabbit sera against the FMDV type O used in
this study were provided by our laboratory.
Real MasterMix (SYBR GREEN) kit was provided by
TaKaRa Biotechnology Co., Ltd. (Dalian, China) and rab-
bit anti-guinea pig IgG which was conjugated with horse-
radish peroxidase (HRP) was provided by Sigma (Sigma,
US).
GNPs with an average diameter of 30 nm were
obtained from Ted Pella Inc (CA, USA). All oligonu-
cleotides and primers were synthesized from Sangon
Co., Ltd. (Shanghai, China) (Table 1).
Preparation of bi-functionalized GNP conjugated with
oligonucleotides and monoclonal antibodies
GNPs bi-functionalized with MAb 1D11 and the conju-
gation DNA were prepared as reported previously [15].
First, the primary gold nanoparticles solution was
adjusted to pH 9.2 with 1 M NaOH. Then, 1 ml of the
solution was mixed with 6 μg MAb 1D11 at room tem-
perature and was mildly shaking for 30 min. This solu-
tion was added with 1 OD thiolated conjunction DNA
for 16 h at 10°C. Then, a procedure of salt-aging was
carried out by adding 2 M NaCl in a six-stepwise-addi-
tion within 24 h to this solution in order to make 0.1 M
of the final concentration of NaCl. 0.3 ml of a 10%
bovine serum albumin (BSA) solution was added into
the solution with extensive incubation at room tempera-
ture for 30 min to stabilize and achieve passivation of
GNPs. The solution was centrifuged at 4°C for 20 min,
and the supernatant was removed. The nanoparticles
were resuspended in 0.1 M phosphate buffered solution
(PBS, pH7.4) and centrifuged again in order to achieve
further purification of nanoparticles. The nanopaticles
were resuspended in the 400 μl PBS with 1 OD of the
signal DNA and hybridized at 37°C for 1 h. The similar
centrifugation procedure was performed to remove the
redundant signal DNA and obtain the bi-functionalized
GNPs. Finally, the probes were resuspended in PBS with
0.01% Tween-20 (v/v) and 0.1% BSA (w/v). This bi-fun-
tionalized GNPs probes solution was stored at 4°C.
Assay for FMDV by ELISA
Conventional ELISA was performed as reported previously
[20]. Each microplate (Corning Costar Inc., US) were
coated with polyconal antibody (10 μg/ml) in 0.1 M carbo-
nate/bicarbonate buffer (pH 9.4) overnight at 4°C. Plates
were blocked with 5% skim milk in PBS and washed three
times with PBST (containing 0.1% Tween-20, pH7.4).
After three times of washing, each microplate was added
with 50 μl of tenfold serial dilutions of the purified FMDV
(1 ug/ml to 0.1 pg/ml) incubated for 1 h at 37°C. The
plates were subsequently washed, then 50 μl MAb 1D11
(1:1000 dilution) was added and incubated for 1 h at 37°C.
After three washings, 50 μl Goat anti-mouse IgG which
was conjugated with horseradish peroxidase (HRP)
(Sigma) was added and incubated for 1 h at room tem-
perature. Three time of washing with PBST, the ELISA
reaction was developed by the addition of ophenylenedia-
mine-H2O2 for 20 min at 37°C. The reaction was stopped
by the addition of 50 μl 1.5 M H2SO4 and the microplate
was read at OD 490 by a plate reader (Bio-Rad 680, USA).
Detection of FMDV by GNP probe
All procedure of coating and blocking for GNP-IPCR
were carried out by same way with the ELISA. The
assay of GNP-IPCR was conducted as described pre-
viously [19]. The microplates were washed using 0.05 M
PBSET (including 5 mM EDTA and 0.05% Tween-20).
50 μl of tenfold serial dilutions of purified FMDV
(10 pg/ml to 0.01 fg/ml) were respectively added into
the microplates and then incubated at 37°C for 1 h, fol-
lowing by five times of washing. Then 50 μl GNP probe
was added into microplates and incubated for 1 h at
37°C, washed five times with PBS, add 50 μl of double
distilled H2O into each microplates. Finally, the plates
were handled in a water bath at 80°C for 10 min to
release the signal DNA which is then analyzed by PCR.
PCR amplification was performed by adding 5 μl of
the free signal DNA as templates (0.2 μM each primers,
1 mM dNTP, 10 × buffer and 2.5 U Taq DNA polymer-
ase). The amplification products were analyzed by 2%
agarose gel electrophoresis.







*dA15 means that there are 15 dA, and SH means that this end of the oligonueotide is modified by alkanthiol group.
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Detection of Real-time PCR for signal DNA
Real time PCR amplification was performed by adding 5
μl of the released signal DNA solutions as templates,
added 0.5 μl forward primer (10 μM) and reverse primer
(10 μM) listed in Table 1 into the MasterMix (SYBR
GREEN) kit in a total volume of 20 μl. The cycling para-
meters were an initial DNA denaturation step at 95°C
for 30 sec followed by 40 cycles of PCR with DNA
denaturation at 95°C for 15 sec and primer annealing
and extension at 68°C for 30 sec.
Detection Clinical FMDV samples using GNP-IPCR
To evaluate whether this method is perfect for clinical
FMDV sample assays, a total of 30 sera, 20 vesicle fluids
of type O of FMDV and 26 negative sera of FMDV and
10 type Asia 1 of FMDV samples were isolated in our
laboratory to be identified by GNP-IPCR.
Results
Detection FMDV Antigen using GNP-IPCR and ELISA
To compare the sensitivity and detection limit between
the GNP-IPCR and ELISA, we applied both GNP-IPCR
and ELISA to detect the purified FMDV antigens. As
shown in Figure 1, the detection limit of ELISA is 100
ng/ml, but the detection limit of GNP-IPCR is about
10 fg/ml of FMDV purified antigens, which was 7
titers of magnitude more sensitive than general ELISA
system.
Detection of FMDV by GNP-IPCR real-time PCR
Gel electrophoresis is a wildly used tool in immuno-
PCR to quantify the PCR amplification, but it has
some shortcoming such as time consuming. Here, a
SYBR green-based fluorescence quantification RT-
PCR was adopted for analysis of the released signal
DNA. As shown in Figure 2, clear distinctness in sig-
nals was found between FMDV samples and the
negative control. The FMDV concentration ranges
from 10 pg/ml to 1 fg/ml, and 1 fg/ml purified
FMDV can be distinguished from the negative control
by this assay.
Detection FMDV Clinical samples using GNP-IPCR
Detection of FMDV clinical sample using GNP-IPCR
indicated that 30 sera, 20 vesicle fluids of type O of
FMDV was identified as positive, 1 negative serum iden-
tified as suspected positive may be due to the sample
contamination, no cross reaction of this assay with sero-
type Asia 1 (Table 2). Owing to its rapidity, sensitivity
and specificity, GNP-IPCR assay is suitable for clinical
diagnosis and surveillance of FMDV, and the whole
assay could be completed within 4 h.
Discussions
ELISA and conventional PCR are standard laboratory
assays which applied to detect FMDV [21-25]. These
assays have been shown restricted on the detection of
FMDV antigen [14] because the ELISA lack of the high
sensitivity, and the PCR can only detect DNA/RNA
朗读. To combine the applicability for detection of anti-
gen of ELISA and the high sensitivity of PCR, Sano et
al., developed the immuno-PCR (IPCR) method [26].
This application is also limited for the lack of standards
related products and difficulty of synthesis of antibody-
oligonucleotides conjugation of IPCR. We are pay atten-
tion to the ability of the BCA-IPCR for detecting
FMDV. This method offers an innovative approach to
detect target proteins that overcomes shortcomings of
Figure 1 Detection of serial dilutions of purified FMDV using GNP-IPCR and ELISA. The detect limit of ELISA was 100 ng/ml purified FMDV
and that of GNP-IPCR was 10 fg/ml.
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IPCR. The method is exquisitely specific because anti-
gens or antibodies bound to GNPs and the GNPs are
directed against two or more distinct epitopes [27-29],
and the method is more convenient and time-saving
than conventional IPCR assays [30-33].
BCA technology combines the advantages of PCR and
ELISA which have a specificity and sensitivity of detec-
tion of clinical samples. The detect limit of GNP-PCR
can be 10 fg/ml purified FMDV samples while detect
limit of conventional ELISA is 100 ng/ml in this study.
The detect limit of this study was lower than the theore-
tical detect limit. This may be due to the influence of
some factors, for example, the combination efficiency of
the monoclonal antibody, the captured efficiency of the
antigen, or the sample contamination [34]. Meanwhile,
the results of detection clinical FMDV samples indicated
that GNP-IPCR assay is suitable for clinical diagnosis
and surveillance of FMDV. To our knowledge, this is
the first report that GNP-PCR was applied in the detec-
tion of FMDV antigen.
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